ARTICLE | Clinical News

SunPharm preclinical data

February 27, 1995 8:00 AM UTC

Research published by University of Florida collaborators shows action of SUNP’s polyamin analogs at the brain cell receptor, with some of the agents able to open the gate controlled by the receptor, and some able to block gate opening.

The receptor and its calcium channel gate have been implicated in Alzheimer’s disease and stroke. ...